29.45

0.75% 0.22

Pre-market: 29.49 0.04 +0.14%

Schrodinger Inc (SDGR)

Overview News Price History Option Chain Financials Why SDGR Down? Discussions Forecast

Schrodinger Inc stock is traded at $29.45, with a volume of 2.03M. It is up +0.75% in the last 24 hours and up +56.90% over the past month. Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Previous Close:

$29.23

Open:

$28.97

24h Volume:

2.03M

Relative Volume:

1.36

Market Cap:

$2.20B

Revenue:

$254.91M

Net Income/Loss:

$-103.48M

P/E Ratio:

-20.98

EPS:

-1.4036

Net Cash Flow:

$-148.35M

1W Performance:

-2.61%

1M Performance:

+56.90%

6M Performance:

+154.54%

1Y Performance:

+54.51%

1-Day Range:

$28.40

$30.24

1-Week Range:

$28.32

$31.59

52-Week Range:

$10.95

$31.59

Schrodinger Inc Stock (SDGR) Company Profile

Name

Schrodinger Inc

Sector

Healthcare (1068)

Industry

Health Information Services (47)

Phone

503-299-1150

Address

1540 BROADWAY, NEW YORK, NY

Employee

850

Twitter

@schrodinger

Next Earnings Date

2026-11-04

Latest SEC Filings

SDGR's Discussions on Twitter

Compare SDGR vs VEEV, TEM, BTSG, TXG, HNGE

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SDGR Schrodinger Inc	29.45	2.20B	254.91M	-103.48M	-148.35M	-1.4036
VEEV Veeva Systems Inc	274.84	44.50B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	82.24	14.93B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	56.02	11.08B	13.65B	169.86M	412.12M	1.0758
TXG 10 X Genomics Inc	84.11	10.96B	638.78M	-22.66M	122.18M	-0.1744
HNGE Hinge Health Inc	91.98	7.42B	646.34M	-512.40M	202.76M	-6.6871

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-15-25	Upgrade	BofA Securities	Neutral → Buy
Sep-30-25	Initiated	Goldman	Neutral
Aug-15-25	Downgrade	Citigroup	Buy → Neutral
Aug-14-25	Initiated	Barclays	Overweight
Jul-03-25	Resumed	Morgan Stanley	Equal-Weight
Jul-02-24	Initiated	Leerink Partners	Outperform
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight
May-05-23	Resumed	Piper Sandler	Overweight
Dec-19-22	Initiated	Goldman	Neutral
Mar-01-22	Initiated	Citigroup	Buy
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-19-21	Initiated	Piper Sandler	Overweight
Nov-11-21	Downgrade	BofA Securities	Buy → Neutral
Oct-13-21	Initiated	Berenberg	Buy
Sep-01-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-25-21	Initiated	Craig Hallum	Buy
Nov-23-20	Upgrade	BofA Securities	Neutral → Buy
Oct-12-20	Upgrade	Jefferies	Hold → Buy
Mar-02-20	Initiated	BMO Capital Markets	Outperform
Mar-02-20	Initiated	Jefferies	Hold
Mar-02-20	Initiated	Morgan Stanley	Equal-Weight

View All

Schrodinger Inc Stock (SDGR) Latest News

Sep 24, 2026

Schrödinger, Inc. (SDGR) Stock Price, News, Quote & History - ca.finance.yahoo.com

Sep 24, 2026

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - TradingView

Sep 24, 2026

Schrödinger stock falls 4.79 percent as ACV growth reaches 27 percent - AD HOC NEWS

Sep 24, 2026

Sep 23, 2026